Fatty Acids in Cancer Therapy: Chemical Conjugates, Nanocarriers, and Therapeutic Opportunities
Gabriela Antal, Nicoleta Anamaria Pașcalău, Elisabeta Atyim, Oana Bătrîna, Codruța Șoica, Marius Mioc, Cristina Tandafirescu, Alexandra Mioc · 2026
Read Fatty Acids in Cancer Therapy: Chemical Conjugates, Nanocarriers, and Therapeutic Opportunities by Gabriela Antal, Nicoleta Anamaria Pașcalău, Elisabeta Atyim, Oana Bătrîna, Codruța Șoica, Marius Mioc, Cristina Tandafirescu, Alexandra Mioc (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13257774.txt.
Description
Gabriela Antal and co-authors review fatty acids as cancer drug partners in a 2026 article. Fatty acids can be chemically tied to drugs, built into nanocarriers, or act directly against tumor cells. Their love of membranes and albumin in blood changes how attached drugs travel and where they land.
Carrier families covered include liposomes, lipid nanoparticles, self-emulsifying systems, and self-assembling prodrugs that release cargo by enzyme action. Conjugation chemistry and its effect on tumor targeting are detailed. Certain unsaturated fatty acids also disturb cancer metabolism, oxidation balance, and death pathways on their own. Medicinal chemists gain an integrated platform view joining chemistry, carrier design, and tumor biology. Clinical translation remains uneven, so the review maps which strategies sit closest to patient testing.
Catalog record
| CREATOR | Gabriela Antal, Nicoleta Anamaria Pașcalău, Elisabeta Atyim, Oana Bătrîna, Codruța Șoica, Marius Mioc, Cristina Tandafirescu, Alexandra Mioc |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 89 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |